SEC Filings | Constellation Pharmaceuticals

SEC Filings

Filing date	Form	Description	Filing Group	View
Apr 13, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-002990.pdf 0001562180-20-002990.rtf 0001562180-20-002990.xls View HTML
Apr 13, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-002991.pdf 0001562180-20-002991.rtf 0001562180-20-002991.xls View HTML
Apr 06, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-20-098890.pdf 0001193125-20-098890.rtf 0001193125-20-098890.xls View HTML
Apr 06, 2020	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0000899243-20-010269.pdf 0000899243-20-010269.rtf 0000899243-20-010269.xls View HTML
Apr 06, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-20-010271.pdf 0000899243-20-010271.rtf 0000899243-20-010271.xls View HTML
Mar 23, 2020	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001209191-20-020724.pdf 0001209191-20-020724.rtf 0001209191-20-020724.xls View HTML
Mar 23, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-20-020732.pdf 0001209191-20-020732.rtf 0001209191-20-020732.xls View HTML
Mar 23, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-20-020728.pdf 0001209191-20-020728.rtf 0001209191-20-020728.xls View HTML
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-002396.pdf 0001562180-20-002396.rtf 0001562180-20-002396.xls View HTML
Mar 10, 2020	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	0001564590-20-009735.pdf 0001564590-20-009735.rtf 0001564590-20-009735.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.